IDEXX Laboratories Inc. 8-K Report: Key Insights & Filing Details

$IDXX
Form 8-K
Filed on: 2025-07-10
Source
IDEXX Laboratories Inc. 8-K Report: Key Insights & Filing Details

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Company Information:
  • Name: IDEXX Laboratories Inc.
  • CIK: 0000874716
  • Location: One IDEXX Drive, Westbrook, ME 04092.
  • Common Stock: Par value of $0.10 per share.
  • Ticker Symbol: IDXX (traded on NASDAQ).
  1. Filing Details:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes).
  • Filing Date: July 10, 2025.
  • SEC File Number: 000-19271.
  • IRS Number: 01-0393723.
  1. Reporting Context:
  • Report Date: The financial report covers a single day—July 10, 2025.
  • Units of Measure:
    • Financial figures are reported in U.S. dollars (USD).
    • Shares are also a unit of measure indicating the number of shares involved.
  1. Financial Metrics:
  • The report does not provide specific financial figures or metrics in this section, but it indicates that the unit of measure is in USD per share, suggesting potential financial data will be included in other parts of the report.
  1. XBRL Tagging:
  • The data is formatted in XBRL (eXtensible Business Reporting Language), which implies structured data that can be easily processed and analyzed.
  1. Schema Reference:
  • The report references a schema file (idxx-20250710.xsd), which may contain definitions and structure for the reported data, indicating adherence to standards for financial reporting.

Summary:

This section of the financial report provides essential details about IDEXX Laboratories, including its basic company information, filing specifics, and the context of the report. However, it lacks detailed financial metrics that would typically accompany such a filing. Further sections of the report would likely provide more substantive financial data and insights.